Conduct of trials in private clinical practice

被引:6
|
作者
Beran, RG [1 ]
Beran, ME [1 ]
机构
[1] Epilepsy Res & Serv, Chatswood, NSW 2067, Australia
关键词
private practice; trials; new drugs; epilepsy research; patients;
D O I
10.1111/j.1528-1157.2000.tb00256.x
中图分类号
R74 [神经病学与精神病学];
学科分类号
摘要
Purpose: Trials of antiepileptic medications are usually based in tertiary referral centers with teaching hospital resources. Epilepsy Research & Services (ERS) is part of a private outpatient neurological clinic that is involved in research as part of multicenter clinical trials, adhering to Good Clinical Research Practice. ERS is subject to external monitoring and auditing, but does so outside of the teaching hospital environment. Methods: The clinic is operated by a neurologist supported by a research assistant, administrative and nursing staff and has no formal university attachment. Patients are recruited for trials from routine referrals for clinical care. The center has formal ties with the ethics committee of the local teaching hospital, but none of the team is formally attached to that hospital. Results: The center conducted trials of zonisamide, oxcarbazepine, gabapentin, remacemide, tiagabine, vigabatrin, felbamate, and lamotrigine both as add-on trials in refractory seizure disorders and as monotherapy trials in de novo epilepsy. More than 200 patients have been recruited for trials at ERS (with some patients being involved in more than one trial). External review endorsed ERS as a superior environment for such research and as a model for other centers. Conclusions: Private practice is a viable alternative for the conduct of clincial trials and should be considered when establishing such protocols. Simplicity of administration and clinical practice, which more closely mirrors standard patient care, may enhance recruitment and management.
引用
下载
收藏
页码:875 / 879
页数:5
相关论文
共 50 条
  • [41] DESIGN AND CONDUCT OF CLINICAL-TRIALS IN OSTEOARTHRITIS
    ALTMAN, RD
    SCANDINAVIAN JOURNAL OF RHEUMATOLOGY, 1990, : 24 - 27
  • [42] The contemporary situation for the conduct of clinical trials in Asia
    Fenn C.G.
    Wong E.
    Zambrano D.
    International Journal of Pharmaceutical Medicine, 2001, 15 (4) : 169 - 173
  • [43] CHALLENGES AND PITFALLS IN THE IMPLEMENTATION AND CONDUCT OF CLINICAL TRIALS
    Correll, Christoph Ulrich
    SCHIZOPHRENIA BULLETIN, 2011, 37 : 299 - 299
  • [44] THE CONDUCT AND PRINCIPLES OF RANDOMIZED CLINICAL-TRIALS
    HAUCK, WW
    CONTROLLED CLINICAL TRIALS, 1982, 3 (01): : 73 - 73
  • [45] The continuing unethical conduct of underpowered clinical trials
    Halpern, SD
    Karlawish, JHT
    Berlin, JA
    JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2002, 288 (03): : 358 - 362
  • [46] Fair conduct and fair reporting of clinical trials
    Rennie, D
    JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 1999, 282 (18): : 1766 - 1768
  • [47] ISSUES IN THE DESIGN AND CONDUCT OF CLINICAL-TRIALS
    HENNEKENS, CH
    JOURNAL OF THE NATIONAL CANCER INSTITUTE, 1984, 73 (06) : 1473 - 1476
  • [48] Conduct of clinical trials in developing countries: a perspective
    Devasenapathy, Niveditha
    Singh, Kavita
    Prabhakaran, Dorairaj
    CURRENT OPINION IN CARDIOLOGY, 2009, 24 (04) : 295 - 300
  • [49] Managing conflicts of interest in the conduct of clinical trials
    Morin, K
    Rakatansky, H
    Riddick, FA
    Morse, LJ
    O'Bannon, JM
    Goldrich, NS
    Ray, P
    Weiss, M
    Sade, RA
    Spillman, MA
    JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2002, 287 (01): : 78 - 84
  • [50] A primer on the design, conduct, and interpretation of clinical trials
    Appel, Lawrence J.
    CLINICAL JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY, 2006, 1 (06): : 1360 - 1367